Metaplastic Breast Cancer Has a Poor Response to Neoadjuvant Systemic Therapy

被引：0
|
作者：
Al-Hilli, Zahraa [1 ]
Jakub, James [1 ]
Visscher, Daniel [1 ]
Ingle, James [1 ]
Goetz, Matthew [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2016年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
0313
引用
收藏
页码：24 / 25
页数：2
相关论文
共 50 条
  • [41] Rapid response of breast cancer to neoadjuvant intramammary testosterone-anastrozole therapy: neoadjuvant hormone therapy in breast cancer
    Glaser, Rebecca L.
    Dimitrakakis, Constantine
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2014, 21 (06): : 673 - 678
  • [42] Impact of metaplastic histology (MpBC) in triple-negative breast cancer (TNBC) patients (pts) receiving neoadjuvant systemic therapy (NAST)
    Yam, Clinton
    Hess, Kenneth R.
    Litton, Jennifer Keating
    Yang, Wei Tse
    Santiago, Lumarie
    Candelaria, Rosalind P.
    Mittendorf, Elizabeth A.
    Murthy, Rashmi Krishna
    Damodaran, Senthil
    Helgason, Thorunn
    Huo, Lei
    Thompson, Alastair Mark
    Barton, Michelle
    Huang, Monica L.
    Arribas, Elsa M.
    Lane, Deanna L.
    Rauch, Gaiane M.
    Adrada, Beatriz E.
    Gilcrease, Michael Z.
    Moulder, Stacy L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [43] Predictive Factors for Response to Neoadjuvant Therapy in Breast Cancer
    Loibl, Sibylle
    von Minckwitz, Gunter
    Untch, Michael
    Denkert, Carsten
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 (10) : 563 - 568
  • [44] Metaplastic Triple-negative Breast Cancer Has a Poorer Response to Neoadjuvant Chemotherapy and Worse Survival Compared to Other Triple-negative Breast Cancer: National Cancer Database Analysis
    Sakai, Takehiko
    Ozkurt, Enver
    Pastorello, Ricardo
    Wong, Stephanie
    Wang, Wei
    Iorgulescu, Bryan
    Lester, Susan
    Ohno, Shinji
    Golshan, Mehra
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 2) : S432 - S433
  • [45] Identifying determinants of pathologic complete response in patients with breast cancer after receiving neoadjuvant systemic therapy
    Chan, Abigail Sy
    Bhargava, Anika
    Chandler, Natasha
    Tavcar, Michelle
    Gunaratnam, Bakeerathan
    Dong, Brian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [46] Quantitative molecular breast imaging for early prediction of neoadjuvant systemic therapy response in locally advanced breast cancer patients
    Patel, Miral M.
    Adrada, Beatriz E.
    Lopez, Benjamin
    Candelaria, Rosalind P.
    Sun, Jia
    Boge, Medine
    Mohamed, Rania M.
    Elshafeey, Nabil
    Whitman, Gary
    Le-Petross, Huong T.
    Santiago, Lumarie
    Scoggins, Marion E.
    Lane, Deanna
    Moseley, Tanya
    Zylberman, Galit
    Saddler, Jerica
    Leung, Jessica W. T.
    Yang, Wei T.
    Valero, Vincente
    Kappadath, S. Cheenu
    Rauch, Gaiane M.
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [47] Factors Responsible for Discordant Response to Neoadjuvant Systemic Therapy in T4b Breast Cancer
    Singhal, A. K.
    Sarkar, D. K.
    Manna, A. K.
    Banerjee, R.
    Santra, Babuji
    [J]. INDIAN JOURNAL OF SURGERY, 2022, 84 (SUPPL 3) : 703 - 707
  • [48] Factors Responsible for Discordant Response to Neoadjuvant Systemic Therapy in T4b Breast Cancer
    A. K. Singhal
    D. K. Sarkar
    A. K. Manna
    R. Banerjee
    Babuji Santra
    [J]. Indian Journal of Surgery, 2022, 84 : 703 - 707
  • [49] Pathologic complete response after neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers
    Myers, Sara P.
    Sevilimedu, Varadan
    Barrio, Andrea V.
    Tadros, Audree B.
    Mamtani, Anita
    Robson, Mark E.
    Morrow, Monica
    Lee, Minna K.
    [J]. NPJ BREAST CANCER, 2024, 10 (01)
  • [50] Precision Imaging: One Step Closer to Pretreatment Prediction of Breast Cancer Response to Neoadjuvant Systemic Therapy
    Rauch, Gaiane M.
    [J]. RADIOLOGY, 2023, 308 (01)
12345